| Drug Name | Adempas (Riociguat) |
|---|---|
| Drug Class |
Anti-hypertension
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Cardiology
|
| Risk |
New contraindication regarding treatment of patients with pulmonary hypertension associated with idiopathic interstitial pneumonias (PH-IIP |
| Dear Healthcare provider letter DHPC |
|